PUBLISHER: The Insight Partners | PRODUCT CODE: 1206331
PUBLISHER: The Insight Partners | PRODUCT CODE: 1206331
The South & Central America hydrocephalus shunts market is expected to grow from US$ 11.99 million in 2022 to US$ 14.09 million by 2028. It is estimated to grow at a CAGR of 2.7% from 2022 to 2028.
Business Synergy Through Strategic Alliances to Bring New Trends to Market
Companies in the hydrocephalus shunts market are implementing strategies such as joint ventures to enlarge their market shares. Moreover, investments in R&D are allowing them to develop advanced technologies and gain more revenues. Many organizations are focusing on developing smart shunts to provide advanced control, diagnosis, and communication with the use of implanted sensors, telemetry components, and feedback control systems. Thus, the trending strategies of collaborations and research associations among key players are expected to contribute to the South & Central America hydrocephalus shunts market growth during the forecast period.
Market Overview
The South & Central America hydrocephalus shunt market is segmented into Brazil, Argentina, and the Rest of South & Central America. The hydrocephalus shunt market growth in South & Central America is attributed to the high prevalence of hydrocephalus, increasing number of key players, and availability of advanced shunts for the treatment.
South & Central America Hydrocephalus Shunts Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Hydrocephalus Shunts Market Segmentation
The South & Central America hydrocephalus shunts market is segmented into by age group, type, product, end user and country.
Based on age group, the South & Central America hydrocephalus shunts market is segmented into pediatric and adults. The pediatric segment held the larger market share in 2022.
Based on type, the South & Central America hydrocephalus shunts market is segmented into ventriculo-peritoneal, ventriculo-atrial, ventriculo-pleural, and lumbo-peritonea. The ventriculo-peritoneal segment held the largest market share in 2022.
Based on product, the South & Central America hydrocephalus shunts market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves segment dominated the market share in 2022.
Based on end user, the South & Central America hydrocephalus shunts market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the market share in 2022.
Based on country, the South & Central America hydrocephalus shunts market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Brazil segment dominated the market share in 2022.
B. Braun Melsungen AG (CHRISTOPH MIETHKE GMBH & CO. KG); HpBio Proteses, inc.; Medtronic; Natus Medical Incorporated; and Spiegelberg GmbH & Co. KG. are the leading companies operating in the South & Central America hydrocephalus shunts market.